研究成果
年分
作者
期刊
研究名稱
2024
Lam SHM, Romiti GF, Olshansky B, Chao TF, Huisman MV, Lip GYH*.
Intern. Emerg. Med. 2024; 19(5):1369-1378. (IF:4.100)
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
2024
Lee BC, Tsai HH, Chen ZW, Chang CC, Huang JZ, Chang YY, Tsai CH, Chou CH, Liao CW, Pan CT, Wu VC, Hung CS, Tsai LK*, Lin YH*,
Hypertens. Res. 2024; 47(3): 608-617. (IF:4.300)
Aldosteronism is associated with more severe cerebral small vessel disease in hypertensive intracerebral hemorrhage.
2024
Lee BC, Chang CC, Kang VJW, Huang JZ, Lin YL, Chang YY, Tsai CH, Chen ZW, Liao CW, Pan CT, Wu VC, Hung CS, Chou CH*, Lin YH*,
Hypertens. Res. 2024; doi: 10.1038/s41440-024-01935-w. (IF:4.300)
Autonomous cortisol secretion promotes vascular calcification in vivo and in vitro under hyperaldosteronism.
2024
Lee DY, Chang CC, Ko CF, Lee YH, Tsai YL, Chou RH, Chang TY, Guo SM*, Huang PH*.
Eur. J. Clin. Invest. 2024; 54(1): e14089. (IF:4.400)
Artificial intelligence evaluation of coronary computed tomography angiography for coronary stenosis classification and diagnosis.
2024
Lee DY, Chen T, Huang WC*, Chou RH, Wu CH, Yang CY*, Lee CY, Lin CC, Tarng DC.
ESC Heart Fail. 2024; 11(1): 189-197. (IF: 3.200)
Systemic vascular resistance predicts high-output cardiac failure in patients with high-flow arteriovenous fistula.
2024
Lee DY, Huang WC*, Wu CH*, Yang CY*.
ESC Heart Fail. 2024;11(3):1810-1811. (IF:3.200)
Reply to:"Non-invasively assessed hemodynamics in patients with high flow arteriovenous fistula and high output cardiac failure".
2024
Lee KH, Yeh JT, Wu ML, Yeh WY, Lip GYH, Chiang CE, Chen CH, Cheng HM*.
Thromb. Res. 2024; 238: 132-140. (IF: 3.700)
Oral anticoagulants and cognitive impairment in patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.
2024
Li CY, Wang WT, Ma SH, Lo LW, Wu CY, Chang WC, Chen YJ, Chen TL*.
Br. J. Dermatol. 2024; doi:10.1093/bjd/ljae438. (IF:11.000)
Association of proprotein convertase subtilisin/kexin type-9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study.
2024
Li M, Huang B, Lam SHM, Ishiguchi H, Liu Y, Olshansky B, Huisman MV, Chao TF, Lip GYH*.
Eur. J. Clin. Invest. 2024; 13:e14347. (IF:4.400)
Long-term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the GLORIA-AF registry.
2024
Li YH*, Wang CC, Hung CL, Wu YW, Hsu CH, Tsou YL, Wang CH, Wu CK, Lin PL, Chang HY, Sung SH, Chen ZW, Juang JMJ, Wang TD, Chen WJ.
Acta Cardiol. Sin. 2024; 40(2): 148-171. (IF: 1.800)
2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.